NEW YORK – With consumer genomics kit sales down and recent layoffs recently announced at Ancestry and 23andMe, not to mention last year’s major restructuring at Helix, many feel the direct-to-consumer market is in decline.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
